VTRS (viatris.com) Rasio nilai perusahaan marang pendapatan

Simbol resmi perusahaan Viatris (VTRS)

Is it worth investing in the global distribution network of affordable medicines Viatris Inc. (VTRS)? The enterprise value-to-annual revenue multiple provides the answer, where 2338.69 serves as the base parameter value. Market capitalization relies on the recognition of legacy brands that generate passive income. Stable cash flows support the business while biosimilars develop, and total pharmacy coverage makes the company an indispensable supplier.

VTRS Viatris Corp: Multiplikator EV/Sales ing interval 23.11.2025 - 20.11.2026

VTRS (Viatris Corp): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
Pambiji fundamental perusahaan:VTRS (viatris.com)
Produk sing diprodhuksi Viatris Inc

The global scale of generic production and strict FDA oversight ensure the market resilience of Viatris Inc. (VTRS). This metric correlates the total enterprise value with sales volume, excluding the impact of debt load to assess the actual efficiency of revenue generation. Analyzing the enterprise value-to-revenue ratio helps determine whether the company's technological potential is overvalued relative to its current operating results.